Bronchoscopy Market Size, Share, and Analysis By Device Type (Flexible, and Rigid) By Usability (Reusable, and Disposable), By Application (Diagnostic and Therapeutic), By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2024-2032

Bronchoscopy is a minimally invasive procedure performed through the bronchoscope to evaluate the airways, lungs, or lymph nodes for irregularities. There are two different types of bronchoscopes are available in the market, flexible and rigid bronchoscopes. According to the National Centre of Biotechnological Information (NCBI), flexible bronchoscopes provide a clear image and are easier to move around inside the bronchus, whereas rigid bronchoscopy is more efficient in the interventional management of airway lesions.

The bronchoscopy market is primarily driven by the increasing prevalence of various respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, acute respiratory tract infection or pneumonia, tuberculosis (T.B.), and lung cancer.

• According to data published by Global Initiative for Chronic Obstructive Lung Disease (GOLD) in 2022, more than 2.2 million new cases of lung cancer were reported in 2020 globally. Such growing number of lung cancer cases globally is expected to surge the demand for bronchoscopy in the near future.

Furthermore, improving reimbursement policies related to bronchoscopes, growing hospital investments in bronchoscopy facilities, and technological advancements are the factors boosting the market growth. In addition, lower surgical complications, faster recovery, effective management of post-surgical pain, and shorter hospital stay accelerates the demand for bronchoscopy.

• According to an article published by the American College of Chest Physicians (CHEST) in September 2022, around 10% of U.S. patients suffering from acute respiratory failure treated with invasive mechanical ventilation (IMV) had a bronchoscopy from 2012 to 2018. The use of bronchoscopy with IMV has increased from 9.5% in 2012 to 10.8% in 2018. The accelerating application of bronchoscopy is expected to positively impact the industry landscape in the coming years.

Moreover, market players are introducing advanced technologies such as robotic-assisted bronchoscopy (RAB), navigational bronchoscopy, augmented fluoroscopy (A.F.), and cone-beam C.T. (CBCT) to offer more accurate diagnostic procedures. Such initiatives undertaken by key players are projected to provide lucrative growth opportunities for the market.

• In May 2022, UC Davis Health performed the first robotic-assisted bronchoscopy procedure. The new robotic platform offers lung cancer diagnosis and removal during one surgery.


• In November 2021, Inspira Health Network introduced a new technology called Monarch navigational bronchoscopy platform. This minimally invasive technology of the company offers more accurate lung cancer diagnoses.

Impact of COVID-19 on the Bronchoscopy Market

The outbreak of the COVID-19 pandemic had a negative impact on the bronchoscopy market due to the decline in visits to hospitals, ambulatory surgical centers, and specialty clinics and lockdown restrictions imposed by various governments globally. These restrictions halted the non-emergency procedures in the hospitals. In addition, the market players offering bronchoscopes witnessed a significant decline in revenues in 2020 compared to 2019.

• For instance, Boston Scientific Corporation registered -0.8% decline in revenue in 2020 compared to 2019. The decline in revenue is due to the halt in the non-elective procedures during COVID-19. 

However, the relaxation of the rules imposed by the government, and the resumption of hospital admissions, and surgical procedures in late 2020 and 2021 are expected to bring the bronchoscopy market to pre-pandemic year.

Key Insights

The report will cover the following key insights:

• Prevalence of Major Pulmonary Diseases by Key Countries


• Key Industry Developments – Partnerships, Mergers, and Acquisitions


• New Product Launches


• Technological Advancements in the Bronchoscopes


• Reimbursement Scenario


• Impact of COVID-19 on the Bronchoscopy Market

Analysis by Usability

The disposable bronchoscopy segment is projected to grow at the highest CAGR over a forecast period. The highest growth rate is due to the various benefits associated with disposable bronchoscopes, such as low readmission rates and cost-effectiveness. Furthermore, the growing focus of market players to introduce disposable bronchoscopes is expected to boost the segment during the forecast period.

• For instance, In April 2021, Olympus Corporation launched a new line of five single-use bronchoscopes called H-SteriScope for advanced diagnostic and therapeutic procedures.

Regional Analysis

To gain extensive insights into the market, Request for Customization

North America accounts for the largest share of the global bronchoscopy market due to the increasing number of bronchoscope procedures and higher prevalence rates of respiratory diseases such as lung cancer.

• For instance, as per data published by the NCBI in April 2020, around 500,000 bronchoscopy procedures are performed annually alone in the U.S. Such a high number of procedures is projected to increase the market in North America.

In addition, technological advancement, favorable reimbursement scenarios of bronchoscopes, and the strong presence of market players in the region are attributed to driving the market growth in North America.

Key Players Covered

The report will include the profiles of key players such as Olympus Corporation, Advin Health Care, Boston Scientific Corporation, Ambu A/S, Broncus Medical Inc., FUJIFILM Holdings Corporation, Karl Storz GmbH, Broncus Medical, Inc., Novatech SA, Pentax Medical, Teleflex Inc. and others.

Segmentation

Key Industry Developments

• In September 2022, FUJIFILM Holdings Corporation extended its pulmonology solutions portfolio with a new slim bronchoscope called EB-710P. The company offers pulmonology and bronchoscopy solutions to improve patient outcomes and early diagnosis.


• In July 2022, Verathon, Inc., a global provider of medical devices, launched BFlex 2.8 Single-use Bronchoscope. BFlex single-use bronchoscopes are designed precisely for the critical needs of the ICU, OR (Operating Room), and E.D. (Emergency Department). The BFlex 2.8 is Verathon's first single-use pediatric bronchoscope and delivers the drivability and image quality needed for airway management, pediatric bronchoscopies, and lung isolation procedures.


• In July 2022, Ambu Inc. announced the FDA Clearance of the fifth-generation single-use bronchoscope. The company extended market leadership in pulmonology by entering the bronchoscopy suite segment following U.S. and European market clearances.